Mohammed
AlAmmar

Represented Nazer Group on its sale of a stake in Bupa Arabia, a public listed insurance company in Saudi Arabia, to Bupa UK.

Represented two Saudi Arabian investors on a joint venture to set up region’s first hybrid, delivery-focused, cloud kitchen and store-front operator.

Represented Saudi Aramco Entrepreneurship Ventures (Wa'ed) on the structuring and acquisition of an early stage start-up business in Saudi Arabia.

Represented Nazer Group and Bupa on a healthcare joint venture and other regulatory and commercial matters pertaining to establishing medical clinics in Saudi Arabia.

Representation of a Saudi Arabian entertainment group in connection with drafting and negotiating franchise and licensing agreements in Saudi Arabia with international F&B and private members clubs operators and franchisors.

Advised Dalma Energy LLC on the merger of its business operations in Oman, Saudi Arabia, the Netherlands with the business operations of KCA Deutag.

Advising mega projects operators and sponsors in Saudi Arabia on various regulatory issues pertaining to real estate, corporate and government procurement matters.

Represented three employees of a major pharmaceutical company in connection with FCPA investigations by the DOJ and the SEC. The investigations focused on certain payments and transactions involving vendors and charitable organizations with which the company had done business in the Middle East.

Represented Riyadh Taqni Fund (Riyadh Capital's venture capital fund) on its acquisition of a minority stake in SURE Technology in Saudi Arabia. SURE is a leading Saudi technology and information security provider.

Represented Gulf Investment Corporation on its acquisition of a minority stake in Sudair Pharmaceutical Company in Saudi Arabia. Sudair Pharma is developing Sudair Specialized Pharmaceutical Complex in the Sudair Industrial City for manufacturing of high-end generic drugs for cancer treatment.

Represented Gulf Capital on the acquisition of 100% of the share capital of Multibrands LLC from Sadita Holding through a CMA fund. Multibrands is a leading Saudi food & beverage distribution business which distributes brands including Alicafe, Alitea, Dole, Ocean Spray, Saladitos, Sweet’n Low, McCain frozen foods and others.

Represented Investcorp on the acquisition of a stake in Bindawood Group, which owns one of the largest chains of grocery stores and related businesses in Saudi Arabia. The transaction was Investcorp’s largest investment in the Middle East to date.

Represented NBK Capital on its acquisition of a minority stake in Sanabel Al Salam, a leading Arabic sweets and confectionary producer and retailer in Saudi Arabia.

Represented Jadwa Investment on the formation of a SR 500 million CMA authorized food industry fund, and investment by such fund in a beverage manufacturing company in Saudi Arabia (awarded “Deal of the Year” by Private Equity World (MENA) in November 2010).

Represented Jadwa Investment on the consortium regarding successful bid and acquisition of a stake in the Saudi Aramco Lubricating Oil Refinery Company (Luberef), in Saudi Arabia (awarded “Most Innovative Islamic Finance Deal of the Year 2008” at the 7th Annual Euromoney’s Islamic Finance Awards 2009) and documentation of a Shari’ah-compliant CMA fund (awarded “Best New Private Equity Fund” by Private Equity World (MENA) November 2008).

Represented Saudia Catering Business – advising a consortium in the USD 200 million privatization of the catering business of Saudi Arabian Airlines.

Represented Cravia Inc. on a wide range of corporate, structuring, and regulatory issues pertaining to corporate and commercial matters of the Saudi Arabian operation.

Represented Johns Hopkins Aramco Healthcare on a wide range of corporate, structuring, and regulatory issues in relation to the healthcare laws and regulations in Saudi Arabia.

Represented Abraaj Capital on formation of 100% foreign owned company licensed to engage in investments in Saudi Arabia and advice on restructuring various investments in Saudi Arabia.

Represented Diaverum on joint venture with the Nazer Group to develop dialysis centers throughout Saudi Arabia, and advice in relation to contract with the Ministry of Health.

Represented GCC-based company on development of greenfield hospitals in Saudi Arabia including all related permit and regulatory issues and acquisition of land.

Represented Bupa Arabia – advising on healthcare regulatory and commercial matters.

Represented Al Noor Hospitals Group plc – counsel on the acquisition of various medical clinics in Dubai, Al Ain and Abu Dhabi.

Represented Al Rajhi Holding – advising on corporate restructuring of group companies in Saudi Arabia.

Represented Al Rajhi Capital and Arcapita Bank advising on the formation of a Saudi Arabian property income fund, and acquisition and sale-lease back of properties (including warehouses) in Saudi Arabia for the fund.

Represented Sadara Chemical – advising on a wide range of matters and project agreements in Saudi Arabia.

Represented Al Rajhi Capital – advising in connection with a proposed private placement of shares of a Saudi Arabian real estate company.

Represented Malaz Capital – advising the formation of CMA real estate funds to acquire, own and operate a residential compound in Riyadh and another compound in the Eastern Province.